Cargando…
Pre-exposure chemoprophylaxis for HIV: It is time
The HIV-1 plague continues unabatedly across sub-Saharan Africa. In Botswana and Swaziland, nearly 40% of the entire adult population is already infected. No current program is capable of slowing the advancing tide. An effective vaccine and widespread treatment are years, if not, decades away. In th...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2004
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC478616/ https://www.ncbi.nlm.nih.gov/pubmed/15238164 http://dx.doi.org/10.1186/1742-4690-1-16 |
| _version_ | 1782121637028560896 |
|---|---|
| author | Smith, Stephen M |
| author_facet | Smith, Stephen M |
| author_sort | Smith, Stephen M |
| collection | PubMed |
| description | The HIV-1 plague continues unabatedly across sub-Saharan Africa. In Botswana and Swaziland, nearly 40% of the entire adult population is already infected. No current program is capable of slowing the advancing tide. An effective vaccine and widespread treatment are years, if not, decades away. In this most urgent situation, I propose that pre-exposure chemoprophylaxis be studied as a means to reduce the spread of HIV-1 among at-risk individuals. |
| format | Text |
| id | pubmed-478616 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2004 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-4786162004-07-21 Pre-exposure chemoprophylaxis for HIV: It is time Smith, Stephen M Retrovirology Hypothesis The HIV-1 plague continues unabatedly across sub-Saharan Africa. In Botswana and Swaziland, nearly 40% of the entire adult population is already infected. No current program is capable of slowing the advancing tide. An effective vaccine and widespread treatment are years, if not, decades away. In this most urgent situation, I propose that pre-exposure chemoprophylaxis be studied as a means to reduce the spread of HIV-1 among at-risk individuals. BioMed Central 2004-07-06 /pmc/articles/PMC478616/ /pubmed/15238164 http://dx.doi.org/10.1186/1742-4690-1-16 Text en Copyright © 2004 Smith; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL. |
| spellingShingle | Hypothesis Smith, Stephen M Pre-exposure chemoprophylaxis for HIV: It is time |
| title | Pre-exposure chemoprophylaxis for HIV: It is time |
| title_full | Pre-exposure chemoprophylaxis for HIV: It is time |
| title_fullStr | Pre-exposure chemoprophylaxis for HIV: It is time |
| title_full_unstemmed | Pre-exposure chemoprophylaxis for HIV: It is time |
| title_short | Pre-exposure chemoprophylaxis for HIV: It is time |
| title_sort | pre-exposure chemoprophylaxis for hiv: it is time |
| topic | Hypothesis |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC478616/ https://www.ncbi.nlm.nih.gov/pubmed/15238164 http://dx.doi.org/10.1186/1742-4690-1-16 |
| work_keys_str_mv | AT smithstephenm preexposurechemoprophylaxisforhivitistime |